YuanSheng Venture Portfolio Companies Biosino, KLN, and Dymed Honored as '2023 Deloitte China Rising Stars in Healthcare'

Recently,Deloitte, in response to the latest development trends in the industry, launched the "China Pharmaceutical Health Rising Star" selection this year — a key sub-project of the "Deloitte High-Tech High-Growth" selection program. It aims to recognize outstanding enterprises that lead in pharmaceutical health segments and possess tremendous growth potential, enabling them to gain industry acknowledgment. With its exceptional professional service capabilities, Deloitte can help companies connect with ecosystem resources and promote the sustainable and healthy development of emerging enterprises in the life sciences and healthcare sectors across multiple dimensions.

Three portfolio companies of Yuansheng Ventures proudly made the list:

Bo sheng ji medicine science and technology (suzhou) co., LTDClinChoice andDymind Honored as "2023 Deloitte China Healthcare Rising Star"